GR852529B - - Google Patents

Info

Publication number
GR852529B
GR852529B GR852529A GR850102529A GR852529B GR 852529 B GR852529 B GR 852529B GR 852529 A GR852529 A GR 852529A GR 850102529 A GR850102529 A GR 850102529A GR 852529 B GR852529 B GR 852529B
Authority
GR
Greece
Prior art keywords
well
cerebral
arterioschlerosis
vasospasmolytic
thromboses
Prior art date
Application number
GR852529A
Other languages
English (en)
Inventor
Jurgen Dr Kleinschroth
Gerhard Dr Satzinger
Karl Dr Mannhardt
Johannes Dr Hartenstein
P Dr Hartmut Osswald
Gunter Dr Weinheimer
Edgar Dr Fritschi
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Publication of GR852529B publication Critical patent/GR852529B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR852529A 1984-10-19 1985-10-18 GR852529B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843438351 DE3438351A1 (de) 1984-10-19 1984-10-19 4-alkoxy-pyrido(2,3-d)pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
GR852529B true GR852529B (el) 1986-02-19

Family

ID=6248308

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852529A GR852529B (el) 1984-10-19 1985-10-18

Country Status (14)

Country Link
US (2) US4681882A (el)
EP (1) EP0180834B1 (el)
JP (1) JPS61100582A (el)
CN (1) CN1004274B (el)
AT (1) ATE45949T1 (el)
AU (1) AU579413B2 (el)
CA (1) CA1257261A (el)
DD (1) DD239794A5 (el)
DE (2) DE3438351A1 (el)
DK (1) DK478585A (el)
ES (1) ES8605519A1 (el)
GR (1) GR852529B (el)
HU (1) HU194227B (el)
ZA (1) ZA857989B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung
DE3501696A1 (de) * 1985-01-19 1986-07-24 Bayer Ag, 5090 Leverkusen Pyridopyrimidine, mehrere verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5059602A (en) * 1990-08-27 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 4-substituted dihydropyrido(4,3-d)pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
DE102006026585A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung
DE102006026583A1 (de) * 2006-06-07 2007-12-13 Bayer Healthcare Aktiengesellschaft Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE525394A (el) *
US3673184A (en) * 1970-09-02 1972-06-27 Dainippon Pharmaceutical Co Certain 2-substituted-5,8-dihydro-5-oxopyrido{8 2,3-d{9 pyrimidine-6-carboxylic acid derivatives
US4271164A (en) * 1979-04-16 1981-06-02 Warner-Lambert Company 6-Substituted-arylpyrido[2,3-d]pyrimidin-7-amines and derivatives
US4361700A (en) * 1980-05-20 1982-11-30 James S. Waldron Pyridopyrimidinone derivatives
US4560753A (en) * 1982-11-05 1985-12-24 Sterling Drug Inc. 2-Substituted-pyrido[2,3-d]pyrimidin-5(8H)-ones
US4432981A (en) * 1982-11-05 1984-02-21 Sterling Drug Inc. 2-(Pyridinyl or hydroxyphenyl)-8-substituted pyrido[2,3-d]pyrimidin-5(8H)-ones
DE3438350A1 (de) * 1984-10-19 1986-04-24 Gödecke AG, 1000 Berlin 4-oxo-pyrido (2,3-d) pyrimidin-derivate, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
US4681882A (en) 1987-07-21
DK478585D0 (da) 1985-10-18
CA1257261A (en) 1989-07-11
DD239794A5 (de) 1986-10-08
DK478585A (da) 1986-04-20
CN85107614A (zh) 1986-07-16
ZA857989B (en) 1986-06-25
HUT39181A (en) 1986-08-28
AU4885685A (en) 1986-04-24
DE3572663D1 (en) 1989-10-05
HU194227B (en) 1988-01-28
JPS61100582A (ja) 1986-05-19
CN1004274B (zh) 1989-05-24
ATE45949T1 (de) 1989-09-15
ES548008A0 (es) 1986-03-16
ES8605519A1 (es) 1986-03-16
EP0180834A1 (de) 1986-05-14
DE3438351A1 (de) 1986-04-24
US4762837A (en) 1988-08-09
AU579413B2 (en) 1988-11-24
EP0180834B1 (de) 1989-08-30

Similar Documents

Publication Publication Date Title
GR852529B (el)
NO880182D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1, 2-dihydro-3h-indazol-3h-indazol-3-on-derivater.
YU138388A (en) Inner part of shoe's sole, especially middle part
EP0179808A4 (en) MEDICINAL COMPOSITION SUITABLE FOR TREATING OR PROPHYLAXIS OF HEART DISORDERS.
EP0150709A3 (en) 7-oxabicycloheptane prostaglandin analogs
AU7983691A (en) 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders
NO871867D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske kondenserte tricykliske forbindelser.
NO874302D0 (no) Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner.
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
SE8301004D0 (sv) Pyridinforeningar
IL72188A0 (en) Imidazoquinazoline derivative and salts thereof,their preparation and pharmaceutical compositions containing them
GR79111B (el)
EP0311322A3 (en) Pyridine or pyridazine derivatives as cardio-protective agents and for the treatment of ischemic disease, and process for their preparation
GR852525B (el)
NO854277L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 6-fenetylaminoalkyl-7-hydroksy-furo-(3,4-c)-pyridin-derivater.
IT1193604B (it) 1,3,4-tiadiazolo (3,2-a) pirimidine sostituite e procedimento per la loro preparazione
AU7731187A (en) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
ZA875916B (en) Process for the preparation of antibacterial 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-ene derivatives
NO167511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater.
NO170545C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6,21-dimethyl-19-nor-pregna-diener
NO880492L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske triazolpyrimidinderivater.
MX5313A (es) Derivados heterociclicos para el tratamiento de trastornos cardiovasculares y procedimiento para obtenerlos.
IT1231936B (it) Procedimento per la preparazione di 2,3 diidro 2,2 dimetilbenzofuran 7 olo.
IT1158251B (it) Perfezionamenti nella connessione dei cestelli alle testate nei colapiatti